About
MedTech International
Commercialising inspired solutions and driving growth for startups and scaleups
MedTech International drives global commercialisation and strategic growth for cutting-edge technologies, helping bold ideas gain traction fast. We partner with innovators to scale strategically, go to market confidently, and grow with purpose.
Discover more about MedTech International and the work we do in board fulfilment, business strategy, and commercialisation
Case Studies:
Pioneering VisionTech
FoodTech Innovation
AgTech Revolution
Case Studies:
Disruptive HealthTech
AgeTech Mentorship & Advisory
MedTech International – turning innovation into impact
At MedTech International, we specialise in accelerating the global commercialisation and strategic growth of high-potential innovations across medical devices, digital health, BioTech, FoodTech, and AgTech.
Founded by industry leader Warren Bingham in 2014, our mission is to help organisations – startups, scaleups or established players – navigate the complex path from proof of concept to commercialisation, with a clear focus on improving patient outcomes, transforming health systems, advancing sustainable food and agriculture innovation, and delivering lasting economic and social value.
Firm foundations
MedTech International is built on over 30 years of industry expertise, spanning commercial strategy, health innovation, and startup growth.
One of the most defining chapters began in 2001, when Warren Bingham established the Australian subsidiary of Given Imaging Ltd, introducing the world-first PillCam® technology to Australia and New Zealand. This capsule-sized, swallowable camera transformed gastrointestinal diagnostics by offering a non-invasive, safe, and cost-effective alternative to traditional procedures.
By 2004, Warren successfully led the inclusion of Capsule Endoscopy onto Australia’s Medicare Benefits Scheme, a global first in national healthcare reimbursement for this technology, and a turning point in patient access and medtech commercialisation.
Whilst serving on the global management team from 2000, the company grew from a startup to a multinational, publicly traded company with revenues exceeding $250 million in 2013. In February 2014, Covidien acquired Given Imaging for approximately $1 billion.
Other notable experience
- Pentax Endoscopy
- Clinical Genomics colorectal cancer Faecal Immunochemical Tests
- Cicada MedLab early-stage startup accelerator program
- AusBiotech/AusMedtech
- Research Australia (health and medical research advocacy)
- Medical Technology Association of Australia (MTAA)
How we support your growth
From Vision to Venture
Whether you’re building the next breakthrough in medical devices, transforming access to healthy food, or reshaping sustainable agriculture, scaling innovation takes more than a pitch deck and a prototype.
Here’s how we help turn early-stage traction into scalable, investable, and impactful ventures:
Built for MedTech & startup ecosystems
We thrive at the intersection of disruptive innovation, digital transformation, and healthcare impact. Whether you’re scaling AI-driven solutions or navigating regulatory pathways and clinical trials, we bring a holistic, cross-functional approach that turns complexity into opportunity.
We help you align your value proposition with your market fit, build strong thought leadership, and apply lean startup methodologies with agile execution to ensure your innovation doesn’t just launch – it lands.
Beyond the accelerator
At MedTech International, we understand that the real journey begins after Demo Day, when startups transition from potential to performance. That’s why we offer hands-on, tailored support to help founders operationalise their vision, commercialise with confidence, and build momentum that lasts.
We guide ventures through:
- Post-accelerator growth & implementation support
- Go-to-market execution & market entry
- Customer acquisition & clinical validation
- Business model optimisation & revenue acceleration
- Investor readiness, follow-on funding & strategic partnerships
- Pilot programs & alumni network access
Together, we turn momentum into measurable outcomes – accelerating your path from idea to impact.
Commercial strategy & sustainable growth
From strategic roadmaps to customer journey mapping, we help teams sharpen their market penetration strategy, engage stakeholders, and scale for impact. Our support includes:
- Validated learning & due diligence preparation
- Access to networks & venture capital connections
- Commercial readiness assessments
- Business model innovation for long-term success
With decades of industry experience and deep ties across the global MedTech, BioTech, and digital health ecosystems, we don’t just consult – we partner. We’re here to make sure you move with purpose, scale with confidence, and grow sustainably.
When you’re ready to move from innovation to impact, get in touch.
Case Studies
MedTech International drives innovation, delivering advanced medical solutions that transform healthcare, cutting-edge technologies that boost sustainable farming and food security, and pioneering food innovations that enhance production, safety, and nutrition worldwide.
Here are a few examples of how we’ve helped founders and organisations turn innovation into impact.
Pioneering VisionTech
ARIA Research is pioneering the world’s first commercially scalable noninvasive bionic vision system, empowering over 338 million blind and vision-impaired people globally to perceive their surroundings through sound. By combining spatial computing, artificial intelligence, and user-centred co-design to create smart glasses, the system translates visual information into immersive 3D auditory cues.
Named 2023 Australian Tech and MedTech Company of the Year, ARIA has leveraged MedTech International’s strategic vision, industry expertise, and advocacy for inclusive innovation, which has been instrumental in its rapid growth and collaborations with leading blindness organisations and government partners. The partnership has been pivotal in driving ARIA’s product development, commercial strategy, and global planning, positioning the technology to deliver real-world impact for people with vision disability.
Read about how ARIA’s smart glasses have been co-designed by the blind community to help people “see” the world through sound here.
FoodTech Innovation
OmnisOva is an Australian biotechnology company focused on developing advanced breeding technology to produce safe eggs for people with severe egg allergies. With the support of a $1.47 million Cooperative Research Centres Project grant and in collaboration with industry and CSIRO, OmnisOva is working to remove ovomucoid (OVM), a key protein responsible for allergic reactions, from chicken eggs. This innovation aims to deliver allergen-safe eggs, addressing a significant unmet need for those who suffer from severe egg allergies.
As Executive Chairman, Warren leads the Board in setting OmnisOva’s strategic direction, strengthening partnerships with CSIRO and securing grant funding.
Warren’s experience in commercialisation and health innovation is helping position OmnisOva as a global leader in allergen-safe food solutions, to make safe eggs accessible to millions worldwide.
AgTech Revolution
Agscent is reinventing livestock diagnostics with non-invasive breath sensing technology that enables rapid, point-of-care pregnancy and disease detection, improving animal welfare, farm productivity, and sustainability.
As Non-Executive Chairman, Warren has played a key role in Agscent’s commercial strategy, product development, and industry partnerships.
His leadership has helped Agscent win industry recognition, commercialise its applications to methane gas measurement, and scale its impact across the agricultural sector, delivering cost savings, operational efficiency, and environmental benefits for farmers worldwide.
Disruptive HealthTech
Vlepis is revolutionising home and remote healthcare through advanced sensing solutions that enable proactive, personalised care.
By capturing and communicating contextual physiological data, Vlepis empowers caregivers and clinicians to make informed decisions and support the well-being of at-risk populations.
Engaging MedTech International for strategic advice and industry knowledge has supported Vlepis in refining its product offering, building partnerships, and aligning its technology with the evolving needs of the healthcare sector, positioning the company for growth in the rapidly expanding remote patient monitoring market.
AgeTech Mentorship & Advisory
Andromeda is transforming aged care by introducing personalised robot companions that bring residents joy, social connection, and improved wellbeing.
Connected through the LaunchVic MedTech Market Growth program, Warren’s mentorship and commercial advice have been vital in helping Andromeda’s founders navigate the complexities of scaling their health technology startup.
Leveraging Warren’s extensive network and expertise in MedTech innovation, MedTech International has provided strategic guidance on business development, funding, and market entry, accelerating Andromeda’s mission to combat loneliness and enhance the quality of life for older Australians.